The US pharmaceutical industry has become a battleground for geopolitical and trade tensions, with the Trump administration threatening tariffs on foreign manufacturers and vowing to reduce prescription drug prices for Americans. This move is part of a broader push to promote US drugmakers' sovereignty. The global pharmaceutical industry is affected by these policies, which aim to reduce costs for American consumers.
The global pharmaceutical industry has found itself at the heart of geopolitical and trade tensions. The Trump administration has pushed policies to promote the sovereignty of US drugmakers, threatening tariffs on manufacturers or countries, and vowing to reduce prescription drug prices for Americans.